A Study to Evaluate the Symptoms over 24 hours in Patients with Chronic Obstructive Pulmonary Disease - LASSYC Study

Trial Identifier: D2287R00119
Sponsor: AstraZeneca
NCTID:: NCT03381560
Start Date: November 2017
Primary Completion Date: June 2018
Study Completion Date: June 2018
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Brazil Blumenau, Brazil, 89030-101
Brazil BOTUCATU, Brazil, 18618970
Brazil Campinas, Brazil, 13083
Brazil Porto Alegre, Brazil, 90035-074
Brazil Rio de Janeiro, Brazil, 20551-030
Brazil Sao Bernardo do Campo, Brazil, 09750-420
Brazil Sao Paulo, Brazil, 04023-062
Brazil São Paulo, Brazil, 5403000